$IEX

IDEX raises 2026 outlook as record sales grow 8% to $952M (IEX:NYSE)

IDEX reported Q3 Non-GAAP EPS of $2.33, exceeding estimates by $0.09. Revenue grew 8.3% year-over-year to $952M, also beating expectations. The company raised its 2026 guidance, targeting organic sales growth of 6.5%–6.8% and adjusted diluted EPS of $8.91–$8.96, above the prior range and consensus.

Original reporting
Published Oct 28, 2026, 11:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 11:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IEX
Bullish
high confidence
Mentioned
$IEX
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$IEXBullishHigh
01

Why it matters

The earnings beat and upgraded FY2026 guidance provide fresh, material information for traders.

02

Market read

The new guidance could drive short‑term price appreciation and influence sector sentiment.

03

What to watch

Potential supply‑chain constraints or macro slowdown could temper the upside.

Relevance 8/10Novelty 8/10Timing: post‑market release

Background

IDEX (IEX) is a US‑listed industrial equipment provider that issued its Q3 earnings press release.

Company-level read

Ticker impact

$IEXBullishHigh confidence
Context

IDEX reported Q3 non‑GAAP EPS of $2.33 beating estimates and raised FY2026 organic sales growth guidance to 6.5%‑6.8% with EPS $8.91‑$8.96.

Expected impact

likely upward pressure as the market prices in the stronger guidance

Evidence & confidence

Earnings beat and higher guidance are fresh material that can move the stock immediately.

Market effects

Improves outlook for the industrial equipment sector as peers may see similar demand trends.

Positive for US industrials, modest spillover to European peers.

Limited to industrials; no broad macro effect.

Counterpoint

If the raised guidance is already priced in, the stock could face a short‑term pullback.

Key entities

  • IDEX

    Industrial equipment manufacturer listed on NYSE under ticker IEX.

Related articles

$IEXMedAI 8/10

IDEX (NYSE:IEX) beats Q3 2026 sales expectations

IDEX reported Q3 2026 revenue of $951.7 million, beating estimates by 1.8%. Adjusted EPS was $2.33, a 4% beat. Adjusted EBITDA reached $264.8 million, a 3.2% beat. Management raised full-year adjusted EPS guidance to $8.94. Operating margin remained steady at 21.9%, while free cash flow margin improved to 22.5%.

$IEXHighAI 9/10

IDEX beats estimates and lifts guidance as orders surge

IDEX Corporation (NYSE:IEX) reported Q3 earnings of $2.33 per share, beating estimates by $0.09, with revenue of $952M, up 8% YoY. Orders rose 13% to $991M. The company raised full-year EPS guidance to $8.91-$8.96 and increased organic sales growth outlook to 6.5%-6.8%. Shares rose 2.4% post-announcement. Growth was driven by AI and semiconductor demand, particularly in the Health & Science Technologies segment.

$IEXHigh

IDEX REPORTS RECORD THIRD QUARTER RESULTS

IDEX CORP /DE/ (IEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Jim Giannakouros, CFA Vice President, Investor Relations (847) 313-9506 IDEX REPORTS RECORD THIRD QUARTER RESULTS Third Quarter Highlights (All comparisons are against the prior year period unless otherwise not

$IEXMed

Q3 Preview: Mizuho Picks Top Electrical Equipment & Multi-Industry Stocks

Mizuho identifies five top industrial and electrical equipment stocks ahead of Q3 2026 earnings, citing strong fundamentals and order momentum. IDEX (IEX) is rated Outperform with a $280 target, expecting 5-7% organic growth. Eaton (ETN) anticipates 13.5-15.5% growth, while Emerson (EMR) faces a $25M headwind. Applied Industrial (AIT) and Dover (DOV) also receive Outperform ratings with growth expectations.